What's new

Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

May 23, 2025 - 18:55
 0
Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Advate, octocog alfa, ...

Next Article

Human medicines European public assessment report (EPAR): Remsima, infliximab, D...

Related Posts

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Nerlynx, neratinib, Date of authorisation: 31/08/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Advisory functions

Advisory functions

May 16, 2025  0